Chayodom Maneechote
Overview
Explore the profile of Chayodom Maneechote including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumfu S, Sripetchwandee J, Thonusin C, Maneechote C, Arunsak B, Chunchai T, et al.
Arch Biochem Biophys
. 2025 Feb;
767:110354.
PMID: 39988036
One of the leading causes of death for individuals with iron overload is iron overload cardiomyopathy (IOC). Iron overload causes cardiac mitochondrial dysfunction, which ultimately results in heart failure and...
2.
Piamsiri C, Maneechote C, Chattipakorn S, Chattipakorn N
J Cell Mol Med
. 2025 Feb;
29(3):e70357.
PMID: 39929748
Ischaemic heart disease (IHD) remains a leading cause of global morbidity and mortality. One significant contributor to the pathology of IHD is the excessive release of inflammatory mediators during the...
3.
Prathumsap N, Ongnok B, Khuanjing T, Arinno A, Maneechote C, Chunchai T, et al.
Toxicol Appl Pharmacol
. 2024 Aug;
491:117074.
PMID: 39168189
Despite its efficacy in human epidermal growth factor receptor 2 positive cancer treatment, trastuzumab-induced cardiotoxicity (TIC) has become a growing concern. Due to the lack of cardiomyocyte regeneration and proliferation...
4.
Piamsiri C, Maneechote C, Jinawong K, Arunsak B, Chunchai T, Nawara W, et al.
Eur J Pharmacol
. 2024 Jun;
977:176736.
PMID: 38878877
Mitochondrial dysfunction and the activation of multiple programmed cell death (PCD) have been shown to aggravate the severity and mortality associated with the progression of myocardial infarction (MI). Although pharmacological...
5.
Suparan K, Sriwichaiin S, Thonusin C, Sripetchwandee J, Khuanjing T, Maneechote C, et al.
Food Chem Toxicol
. 2024 May;
189:114741.
PMID: 38759714
An impact of donepezil against doxorubicin-induced gut barrier disruption and gut dysbiosis has never been investigated. Twenty-four male Wistar rats were divided into three groups. Each group was treated with...
6.
Khuanjing T, Ongnok B, Maneechote C, Siri-Angkul N, Prathumsap N, Arinno A, et al.
Pharmacol Res
. 2024 Apr;
203:107147.
PMID: 38565498
No abstract available.
7.
Maneechote C, Chattipakorn S, Chattipakorn N
Life Sci
. 2024 Mar;
344:122575.
PMID: 38492920
Increasing global obesity rates and an aging population are independently linked to cardiac complications. Consequently, it is crucial to comprehensively understand the mechanisms behind these conditions to advance innovative therapies...
8.
Jinawong K, Piamsiri C, Apaijai N, Maneechote C, Arunsak B, Nawara W, et al.
Curr Neuropharmacol
. 2024 Feb;
22(10):1749-1760.
PMID: 38362882
Background: We have previously demonstrated that oxidative stress and brain mitochondrial dysfunction are key mediators of brain pathology during myocardial infarction (MI). Objective: To investigate the beneficial effects of mitochondrial...
9.
Yarana C, Maneechote C, Khuanjing T, Ongnok B, Prathumsap N, Thanasrisuk S, et al.
Curr Res Toxicol
. 2023 Nov;
5:100134.
PMID: 37964944
Late-onset cardiomyopathy is becoming more common among cancer survivors, particularly those who received doxorubicin (DOXO) treatment. However, few clinically available cardiac biomarkers can predict an unfavorable cardiac outcome before cell...
10.
Kumfu S, Sripetchwandee J, Thonusin C, Sumneang N, Maneechote C, Arunsak B, et al.
Toxicol Appl Pharmacol
. 2023 Oct;
479:116727.
PMID: 37863361
Iron overload cardiomyopathy (IOC) is the leading cause of death in cases of iron overload in patients. Previous studies demonstrated that iron overload led to cardiomyocyte dysfunction and death through...